FDC vs WINDLAS: Stock Comparison

FDC Limited vs Windlas Biotech Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

FDC Limited is the larger company by market capitalisation. FDC Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of FDC Limited and Windlas Biotech Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FDC is more favourable on 12 of 13 scored metrics and WINDLAS on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
FDC is the larger company
₹6,606 Cr vs ₹1,775 Cr
P/E Ratio
FDC has a lower P/E
23.92x vs 27.23x
P/B Ratio
FDC has a lower P/B
2.71x vs 3.12x
EPS
WINDLAS has higher earnings per share
₹31.5 vs ₹17.27
Dividend Yield
FDC has a higher dividend yield
2.42% vs 0.73%
Revenue Growth (TTM YoY)
FDC has faster revenue growth
18.9% vs 17.7%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs -2.6%
Qtr Sales Growth
FDC has stronger quarterly sales growth
18.9% vs 17.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCWINDLAS
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCWINDLAS
Live Price₹412.95₹857.95
Day Change2.92%-0.41%
Volume96,77831,663
52-Week High₹527.8₹1,097.9
52-Week Low₹312.95₹697.4
Distance from 52W High-21.76%-21.86%

Valuation

MetricFDCWINDLAS
Market Cap₹6,606 Cr₹1,775 Cr
P/E Ratio23.92x27.23x
P/B Ratio2.71x3.12x
EPS₹17.27₹31.5
Book Value₹152.62₹275
Dividend Yield2.42%0.73%

Growth

MetricFDCWINDLAS
Revenue Growth (TTM YoY)18.9%17.7%
EPS Growth (TTM YoY)166.8%-2.6%
Qtr Sales Growth18.9%17.7%
Qtr Profit Growth167%-1.78%

Profitability & Leverage

MetricFDCWINDLAS
ROE12.5%12.2%
ROCE16.7%15.9%
Net Margin12.96%7.35%
Operating Margin15.9%11.6%
Debt to Equity0.01x0.06x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFDCWINDLAS
Promoter Holding69.66%63.31% 1.41 pp
FII Holding1.4% 1 pp2.04% 1.44 pp
DII Holding6.31% 0.02 pp9.84% 1.97 pp
Public Holding22.63% 0.98 pp24.8% 0.9 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC Limited and Windlas Biotech Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.